Moderation over indulgence: The shift in alcohol trends this year

U.S. consumer preferences are shifting toward moderation: Gallup finds 53% of adults view drinking in moderation as unhealthy, and younger Gen Z cohorts are consuming less alcohol while favoring low-ABV and non‑alcoholic options. Industry sources cite the COVID-19 pandemic as a catalyst and note demand for higher-quality, lower-ABV drinks and crafted mocktails, signaling a potential headwind for traditional high-ABV producers and an opportunity for beverage companies and on-premise operators to innovate in non‑alcoholic and low‑alcohol offerings.

Analysis

Market structure: The moderation trend benefits premium spirits and non‑alcoholic/low‑ABV suppliers (Diageo DEO, Brown‑Forman BF.B, Coca‑Cola KO for mixers) while pressuring mass‑market beer producers (Anheuser‑Busch BUD, Molson Coors TAP) and low‑margin on‑premise operators. Pricing power should migrate to premium/NA SKUs where a 5–15% lower volume can be offset by 10–25% higher ASPs; commodity demand (barley/hops) may decline modestly (low single digits over 2–3 years). Fixed‑cost leverage will compress margins for large brewers with >50% on‑premise exposure and for highly levered regional chains.

Risk assessment: Tail risks include a fast behavioral reversion (pandemic wanes or macro recovery) that restores on‑premise volume, or regulatory moves taxing NA claims; both could flip winners/losers in 3–6 months. Immediate (weeks) sensitivity: summer on‑premise volumes and festival calendars; short term (3–12 months): product launches and retailer shelf shifts; long term (2–5 years): cohort consumption patterns cement or fade. Hidden dependencies: discretionary income, bar innovation (mocktail quality), and distributor shelf slots; catalysts include large brand NA launches or major health studies altering perceived harm.

Trade implications: Construct a paired exposure: overweight DEO (1–2% NAV) and BF.B (1% NAV) vs short BUD (1% NAV) and TAP (0.5% NAV); target net directional skew to premium spirits. Use options to hedge timing: buy DEO Jan 2026 calls (10–12 month) funded by BUD 3–6 month put spreads to exploit near‑term summer softness. Rotate from brewery equity into consumer staples and select restaurant operators that monetize higher non‑alc spend; scale positions around Q2 earnings and June retail on‑premise volume prints.

Contrarian angle: Consensus underestimates offset from premiumization — revenue per adult can rise even as volumes fall, mirroring Big Tobacco’s tactic of price mix recovery after volume declines. The market may over‑discount branded spirits; if on‑premise volumes fall <5% YoY, spirits revenue likely holds, making broad brewery shorts overdone. Watch for consolidation opportunities (M&A) among mid‑cap brewers and NA beverage makers if valuations compress more than 20% relative to peers.

Key Decisions for Investors

• Establish a 1–2% NAV long position in Diageo (DEO) within 2–6 weeks, targeting upside from premium and non‑alcoholic SKUs; add another 0.5% if on‑premise US volumes decline >5% YoY on June retail reports.
• Initiate a 1% NAV short position in Anheuser‑Busch (BUD) and a 0.5% short in Molson Coors (TAP), expecting margin pressure and volume loss into summer; widen exposure if share price underperforms peers by >10% over 2 months.
• Buy DEO Jan 2026 calls (size 0.5–1% NAV) financed by selling BUD 3–6 month put spreads (strike ≈ 95–100% of spot) to capture 6–12 month divergence while limiting capital at risk.
• Overweight KO/PEP by +1% NAV (consumer staples) to capture NA/mixer demand and distributor shelf advantages; underweight brewery ETF (e.g., PBW? or industry ETF) by −1.5% and redeploy into staples within 30 days of this note.
• If branded spirits stocks fall >15% on macro risk without fundamental downgrades, prepare a 1% NAV opportunistic buy for consolidation candidates (mid‑cap brewers/NA brands) within 3–9 months, targeting >30% IRR on 18‑36 month exit.